CXCR4 and neoplasm: Compared with [68Ga]Ga-/[177Lu]Lu-PSMA, an already established theranostics agent that attaches to the prostate-specific membrane antigen (PSMA) present on the neovasculature of many tumor types [19], CXCR4 is present on both the neovasculature and the tumor cells.